Iris Dorbian

OpenView recruits Smith as venture partner

OpenView has named Ashley Smith as a venture partner. Previously, Smith worked at GitHub where she was the vice president of marketing.

Biopharma firm Poseida Therapeutics racks up $142 mln Series C

San Diego-based Poseida Therapeutics, a biopharmaceutical company, has raised $142 million in Series C funding. Novartis Pharma AG led the round.

CleanSpark nets $20 mln

San Diego-based CleanSpark, a microgrid and custom electrical equipment company, has secured $20 million in funding. The investors were not named.

Kleiner Perkins leads Series A round for Stord

Atlanta-based Stord, a provider of next-generation warehousing and distribution, has secured $12.3 million in Series A funding, according to a blog post on its site. Kleiner Perkins led the round with participation from other investors that included Susa Ventures and Dynamo.

VC-backed digital life insurance platform Covr opens Hartford corporate office

Covr Financial Technologies, a digital life insurance platform, has opened its corporate office in downtown Hartford, Connecticut. Covr Technologies was founded in Boise, Idaho. Covr's backers include Nyca Partners, Commerce Ventures, Connectivity Capital Partners and Contour Venture Partners.

VC-backed CloudBees buys Electric Cloud

CloudBees has acquired Electric Cloud, a provider of continuous delivery and application release automation solutions. No financial terms were disclosed. CloudBees is backed by Matrix Partners, Lightspeed Venture Partners, Verizon Ventures, Delta-v Capital, Golub Capital and Unusual Ventures.

VC-backed Onfido appoints CTO and CRO

Onfido, a identity verification provider, has named Kevin Goldsmith and Thomas Ammirati as chief technology officer and chief revenue officer, respectively. Also, Onfido has added Frank van Veenendaal, former chief sales officer and vice chairman of Salesforce, to its board. Onfido's backers include SBI Investment and Salesforce Ventures.

Hookipa Pharma debuts IPO

New York and Austria-based Hookipa Pharma, a developer of immunotherapeutics, has raised $84 million for its IPO after pricing its 6 million shares at $14 per share. The stock began trading April 18, 2019 on the NASDAQ under the ticker symbol “HOOK." BofA Merrill Lynch, SVB Leerink and RBC Capital Markets are the lead underwriters. Hookipa's pre-IPO backers included HBM Partners, Hillhouse Capital, Sirona Capital, Gilead, Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners.

Idinvest Partners leads funding round for Alsid

Paris-based Alsid, an active directory protection solution provider, has secured 13 million euros in funding. Idinvest Partners led the round.

Biopharma startup Nocion nabs $27 mln Series A

Cambridge, Massachusetts-based Nocion Therapeutics, a biopharmaceutical startup, has raised $27 million in Series A funding. F-Prime Capital Partners and Canaan led the round with participation from Partners Innovation Fund and BioInnovation Capital.